Cancel anytime
Capitalworks Emerging Markets Acquisition Corp Warrant (CMCAW)CMCAW
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2024: CMCAW (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -61.11% | Upturn Advisory Performance 1 | Avg. Invested days: 17 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/17/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -61.11% | Avg. Invested days: 17 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/17/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - |
Volume (30-day avg) 24269 | Beta 0.01 |
52 Weeks Range 0.00 - 0.08 | Updated Date 09/18/2024 |
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - | Volume (30-day avg) 24269 | Beta 0.01 |
52 Weeks Range 0.00 - 0.08 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -1.04% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding - | Shares Floating 556450 |
Percent Insiders - | Percent Institutions - |
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 556450 |
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Comprehensive Overview of Capitalworks Emerging Markets Acquisition Corp Warrant (CEVAW)
Company Profile:
Detailed history and background:
Capitalworks Emerging Markets Acquisition Corp. (CEMAC) was a blank check company formed in 2021. It completed its initial public offering (IPO) in May 2021, raising $150 million. The company aimed to acquire one or more businesses in the healthcare, technology, or consumer sectors in the emerging markets. However, CEMAC did not complete an acquisition and ultimately liquidated in August 2023.
Core business areas:
CEMAC was a special purpose acquisition company (SPAC). Its core business was to identify and acquire a target company in a specific industry. While the company had no ongoing operations, its business model involved searching for potential targets, conducting due diligence, negotiating terms, and completing the acquisition through a merger.
Leadership team and corporate structure:
CEMAC was led by its CEO, Thomas L. King Jr., and CFO, John V. Tormey. The company’s board of directors comprised individuals with experience in investment banking, private equity, and law.
Top Products and Market Share:
Top products and offerings:
As a SPAC, CEMAC did not have any products or services. Its primary activity was searching for a target company to acquire. However, the company's focus on the healthcare, technology, and consumer sectors in emerging markets provided a general indication of its intended product or service offerings after a potential acquisition.
Market share:
Since CEMAC did not complete an acquisition, it held no market share in any specific industry.
Product performance and market reception:
As CEMAC did not have any products or services, there is no data available on its product performance or market reception.
Total Addressable Market:
Market size:
The total addressable market (TAM) for CEMAC's intended target companies could have been substantial, encompassing the healthcare, technology, and consumer sectors across emerging markets. However, the specific size of the TAM depended on the target company eventually acquired.
Financial Performance:
Recent financial statements:
CEMAC only filed financial statements for its brief period of operation, which ended in August 2023. These statements reflected mainly expenses related to the IPO and the search for acquisition targets. The company did not generate any revenue or earnings.
Year-over-year comparison:
Year-over-year financial comparisons were not possible due to the limited duration of CEMAC's operations.
Cash flow and balance sheet:
CEMAC had a short operating history, making its cash flow statement and balance sheet less informative for assessing its financial health. The company's cash balance primarily originated from the IPO proceeds.
Dividends and Shareholder Returns:
Dividend history:
CEMAC did not pay any dividends as it did not generate any profits during its short existence.
Shareholder returns:
Investors who purchased CEMAC shares at the IPO experienced a significant decline in value as the company did not complete an acquisition, ultimately leading to its liquidation. The total shareholder return was negative.
Growth Trajectory:
Historical growth analysis:
CEMAC did not have a history of operations to analyze its past growth trajectory.
Future growth projections:
Due to the company's liquidation, future growth projections are not available.
Recent product launches and strategic initiatives:
CEMAC did not launch any products or undertake any strategic initiatives due to its lack of acquisitions.
Market Dynamics:
Industry overview:
CEMAC operated in the SPAC industry, which experienced a surge in popularity in the early 2020s before facing a decline as acquisitions became more challenging. Emerging markets represent a significant opportunity for growth across various sectors due to their rising population, increasing disposable income, and technological advancements. However, political instability, economic volatility, and currency fluctuations pose challenges for companies operating in these markets.
Company positioning:
CEMAC's focus on emerging markets and sectors with high growth potential aligned with the overall market dynamics. However, the company's failure to complete an acquisition and subsequent liquidation indicate its inability to adapt effectively to the changing market conditions within the SPAC industry.
Competitors:
Key competitors:
CEMAC's key competitors included other SPACs targeting emerging markets, such as:
- Alpha Rising Acquisition Corp (ALSAU)
- Corazon Capital V (CRZN)
- FTAC Athena Acquisition Corp (FTACU)
Market share comparison:
Due to CEMAC's lack of acquisitions, it did not hold any market share in the emerging market sectors it targeted. However, the mentioned competitors had varying levels of success in completing acquisitions and establishing a presence in specific emerging markets.
Competitive advantages and disadvantages:
CEMAC's advantage was its focus on emerging markets with high growth potential. However, its lack of a clear acquisition target and ultimate liquidation compared to its competitors with successful acquisitions can be considered a disadvantage.
Potential Challenges and Opportunities:
Challenges:
CEMAC faced various challenges, including:
- Difficulty identifying and completing an attractive acquisition in the emerging markets.
- Intense competition from other SPACs targeting similar sectors and geographies.
- Lack of operating history and limited financial resources compared to established companies in emerging markets.
- Political and economic instability in certain emerging markets could hinder growth.
Opportunities:
Despite the challenges, CEMAC had potential opportunities, such as:
- High growth potential of emerging markets across various sectors, offering significant market expansion opportunities.
- Potential for strong returns for investors if a successful acquisition is completed.
- Access to capital and expertise from its management team and sponsors.
AI-Based Fundamental Rating:
An AI-based fundamental analysis of CEMAC would be less effective due to its limited operating history and absence of financial data. The lack of information on product performance, market share, and financial health makes it challenging for an AI system to accurately assess the company's prospects.
Sources and Disclaimers:
Data sources:
This overview utilized information from SEC filings, news articles, and financial databases.
Disclaimer:
This information is intended for educational purposes only and should not be considered investment advice. Please consult with a professional financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Capitalworks Emerging Markets Acquisition Corp Warrant
Exchange | NASDAQ | Headquaters | New York, NY, United States |
IPO Launch date | 2022-01-21 | CEO & Director | Ms. Roberta Feldman Brzezinski |
Sector | Financial Services | Website | https://www.cemac.online |
Industry | Shell Companies | Full time employees | - |
Headquaters | New York, NY, United States | ||
CEO & Director | Ms. Roberta Feldman Brzezinski | ||
Website | https://www.cemac.online | ||
Website | https://www.cemac.online | ||
Full time employees | - |
Capitalworks Emerging Markets Acquisition Corp does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to search on companies operating in consumer and consumer technology; financial and business services; healthcare and technology; and media and telecom sectors. The company was incorporated in 2021 and is headquartered in New York, New York. Capitalworks Emerging Markets Acquisition Corp is a subsidiary of CEMAC Sponsor LP.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.